SHSE:688319 (China)
Â
Class A
Â¥
27.01
+0.090 (+0.33%)
Jul 23
Business Description
Chengdu Olymvax Biopharmaceuticals Inc
ISIN : CNE1000051H8
Share Class Description:
SHSE:688319: Class ATotal Employee Number:
451Compare
Compare
Traded in other countries / regions
688319.China Index Membership
SSE Composite Index IPO Date
2021-06-08Description
Chengdu Olymvax Biopharmaceuticals Inc is engaged in the research and development, production, and sales of human vaccines, focusing on innovative products.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.45 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.47 | |||||
Debt-to-EBITDA | 5.03 | |||||
Interest Coverage | 7.26 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 6.68 | |||||
Beneish M-Score | -2.33 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.7 | |||||
3-Year EBITDA Growth Rate | 5.2 | |||||
3-Year EPS without NRI Growth Rate | 128.9 | |||||
3-Year Book Growth Rate | 0.8 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 24.96 | |||||
9-Day RSI | 31.03 | |||||
14-Day RSI | 35.57 | |||||
3-1 Month Momentum % | 34.45 | |||||
6-1 Month Momentum % | 48.56 | |||||
12-1 Month Momentum % | 75.44 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.36 | |||||
Quick Ratio | 1.26 | |||||
Cash Ratio | 0.26 | |||||
Days Inventory | 461.92 | |||||
Days Sales Outstanding | 301.23 | |||||
Days Payable | 742.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -0.42 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 92.68 | |||||
Operating Margin % | 14.1 | |||||
Net Margin % | 7.3 | |||||
EBITDA Margin % | 11.16 | |||||
FCF Margin % | 0.03 | |||||
OCF Margin % | 13.37 | |||||
ROE % | 6.09 | |||||
ROA % | 2.94 | |||||
ROIC % | 7.54 | |||||
3-Year ROIIC % | 3.43 | |||||
ROC (Joel Greenblatt) % | 10.85 | |||||
ROCE % | 6.76 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 192.93 | |||||
Forward PE Ratio | 245.54 | |||||
PE Ratio without NRI | 148.41 | |||||
PS Ratio | 14.13 | |||||
PB Ratio | 11.77 | |||||
Price-to-Tangible-Book | 19.57 | |||||
Price-to-Free-Cash-Flow | 27010 | |||||
Price-to-Operating-Cash-Flow | 105.92 | |||||
EV-to-EBIT | 129.09 | |||||
EV-to-EBITDA | 129.09 | |||||
EV-to-Revenue | 14.4 | |||||
EV-to-FCF | 46282 | |||||
Price-to-GF-Value | 1.17 | |||||
Price-to-Graham-Number | 11.35 | |||||
Earnings Yield (Greenblatt) % | 0.77 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chengdu Olymvax Biopharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 774.474 | ||
| EPS (TTM) (Â¥) | 0.14 | ||
| Beta | 1.3896 | ||
| 3-Year Sharpe Ratio | 0.62 | ||
| 3-Year Sortino Ratio | 1.07 | ||
| Volatility % | 56.61 | ||
| 14-Day RSI | 35.57 | ||
| 14-Day ATR (Â¥) | 3.439108 | ||
| 20-Day SMA (Â¥) | 36.5035 | ||
| 12-1 Month Momentum % | 75.44 | ||
| 52-Week Range (Â¥) | 19.99 - 44.9 | ||
| Shares Outstanding (Mil) | 405.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chengdu Olymvax Biopharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chengdu Olymvax Biopharmaceuticals Inc Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chengdu Olymvax Biopharmaceuticals Inc Frequently Asked Questions
What is Chengdu Olymvax Biopharmaceuticals Inc(SHSE:688319)'s stock price today?
The current price of SHSE:688319 is ¥27.01. The 52 week high of SHSE:688319 is ¥44.90 and 52 week low is ¥19.99.
When is next earnings date of Chengdu Olymvax Biopharmaceuticals Inc(SHSE:688319)?
The next earnings date of Chengdu Olymvax Biopharmaceuticals Inc(SHSE:688319) is .
Does Chengdu Olymvax Biopharmaceuticals Inc(SHSE:688319) pay dividends? If so, how much?
Chengdu Olymvax Biopharmaceuticals Inc(SHSE:688319) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Chengdu Olymvax Biopharmaceuticals Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers